Advanced Purification for Complex Biologics

Heightened attention from regulators on product and process quality is causing movement away from traditional mAb platforms to tailored, modified processes for complex biologics, creating a huge unmet need for a platform for experts dedicated to purification alone.

The Advanced Purification for Complex Biologics Summit is the only standalone conference focused on purification for biologics and novel modalities bringing together purification, CMC and MSAT professionals to collaborate and remove purification bottlenecks to meet market delivery timelines.

This in-depth 3-day event will feature the latest breakthroughs and cutting-edge content in AI and digital learning tools to help you save time during downstream processing and boost efficiency.

This is your unique opportunity to meet 60+ purification and downstream processing experts including Sanofi and Takeda, Eli Lilly and Co, AstraZeneca, Regeneron and more as they talk you through machine learning, predictive modelling, and consumables advancements to empower your process optimization, moving a step closer to 100% product purity.

URLs:
Tickets: https://go.evvnt.com/1893273-2?pid=185
Brochure: https://go.evvnt.com/1893273-3?pid=185

Prices:
Drug Developer Pricing - Conference + 1 Workshop: USD 3648.00,
Drug Developer Pricing - Conference Only: USD 2999.00,
Academic Pricing - Conference + 1 Workshop: USD 3148.00,
Academic Pricing - Conference Only: USD 2599.00,
Solution Provider Pricing - Conference + 1 Workshop: USD 4548.00,
Solution Provider Pricing - Conference Only: USD 3799.00

Speakers: André Guillaume, Process Lead Purification, Facilities of the Future, Plasma Derived Therapies, Takeda, Brian Hall, Head of US Biologics Characterization, Expression and Purification, Sanofi, Daniel Ragheb, Senior Scientist - Manufacturing Sciences and Technology, AstraZeneca, Frank Agbogbo, Vice President - Process Development, Forge Biologics, Hilary Williams, MSAT Process Engineer, Genentech, James Reilly, Associate Director, Purification Development, Regeneron, Ji Zheng, Downstream Process Development, Bristol Myers Squibb, Kalie Mix, Principal Scientist, Lab Head, Large Molecule Research, Sanofi, Mi Jin, Senior Director, Head of Downstream and Drug Product Development, Spark Therapeutics, Onur Kas, Head Of Gene Therapy Vector Core, UCB, Paridhi Agrawal, Engineering Advisor, Eli Lilly and Co., Sudha Babu, Director/CMC Regulatory Lead, Spark Therapeutics, Ujwal Patil, Senior Scientist, AstraZeneca, Virginia Brophy, Principal Scientist, Lab Head, Large Molecule Research, Sanofi, Xiaolong Lyu, Director of Downstream Process Development, University of Pennsylvania, Yanhuai (Richard) Ding, Former Head of Purification Process Development, Gene Therapy, (formerly) Biogen, Yonatan Abune, Senior Engineer - Process Development and Analytics, Myeloid Therapeutics

Time: 1:00 pm to 4:00 pm